Should patients with RA be aggressively monitored for hypertension? Commentary

Nature Clinical Practice Rheumatology

Volumn 4, Issue 1, 2008, Pages 18-19

  Dessein, Patrick H ^a   Norton, Gavin R ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LIPID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

AGE DISTRIBUTION; BODY MASS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FUNCTION; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; MULTIVARIATE ANALYSIS; OBESITY; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SHORT SURVEY; SMOKING; UNITED KINGDOM;

EID: 38049048833     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0678     Document Type: Short Survey

References (5)

1. Primatesta P and Poulter NR (2006) Improvement in hypertension management in England: Results from the Health Survey for England 2003. J Hypertens 24: 1187-1192
2. Dessein PH et al. (2007) Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol 34: 943-951
3. Gonzalez A et al. (2007) Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-RA patients? Ann Rheum Dis [doi:10.1136/ard.2006.059980]
4. Fine LJ and Cutler JA (2006) Hypertension and the treating physician: understanding and reducing therapeutic inertia. Hypertension 47 319-320
5. Boers M et al. (2004) Making an impact on mortality in rheumatoid arthritis: Targeting cardiovascular comorbidity. Arthritis Rheum 50: 1734-1739